Expert Rev Mol Diagn. 2010;10(1):49-64. With the ultimate goal of enabling personalized medicine for PC, massive efforts have been undertaken to identify new and better diagnostic, prognostic and ...
Microarray expression profiling of tumor samples for biomarker discovery is based on the assumption that gene expression patterns are major determinants of cancer cell behavior. Using microarray ...
Prostate cancer is the most common internal cancer and the second most frequent cause of death from cancer among men in the United States. 1 In Japan, despite the lower incidence of prostate cancer ...
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients Measurements of tissue ...
Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer The incidence of prostate cancer is frequent, occurring in almost ...
SOUTH SAN FRANCISCO, Calif., December 05, 2024--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic ...
NICE has developed a medtech innovation briefing (MIB) on the Prolaris gene expression assay for assessing long-term risk of prostate cancer progression. The Prolaris test is a multi-gene assay ...
Neighborhood disadvantage is associated with greater expression of stress-related genes that are linked to more aggressive prostate cancer. Men from disadvantaged neighborhoods have higher expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback